Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia
CompletedOBSERVATIONAL
Enrollment
47
Participants
Timeline
Start Date
December 31, 2013
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
Conditions
Bipolar 1 DisorderSchizophreniaMental DisorderNervous System Disorders
Trial Locations (5)
Unknown
Garden Grove
Atlanta
Decatur
Rockville
Bellevue
All Listed Sponsors
lead
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY
NCT02050854 - Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia | Biotech Hunter | Biotech Hunter